IDDI
Biotechnology ResearchNorth Carolina, United States51-200 Employees
IDDI is a biotechnology research firm that provides clinical data science and biostatistical services to support pharmaceutical, biotechnology, and medical device/diagnostic development. With decades of experience, the company combines therapeutic expertise, regulatory insight, and statistical leadership to help clients move from study design through registration and beyond, aiming to ensure data quality and readiness for submission. Its offerings cover biostatistics, study design, regulatory and clinical consultancy, data management, independent data monitoring committees, and supporting eClinical technologies, with an emphasis on accuracy and patient-centered data handling. Based in Raleigh, North Carolina, IDDI has a history of delivering agile trial services and integrating data management and RTSM-EDC solutions to manage complex clinical programs. Recent developments include leadership changes and strategic collaborations, such as a notable executive appointment and a partnership indicating continued expansion of its RTSM capabilities. The company positions itself within the clinical research services sector, serving sponsors across pharma, biotech, and diagnostics to help ensure clinical data is submission-ready and compliant with regulatory expectations. IDDI emphasizes a long-standing commitment to high standards in clinical data science, underpinned by extensive experience and regulatory know-how.